Report Detail

Pharma & Healthcare Global Intravenous (IV) Iron Drugs Market Insights, Forecast to 2025

  • RnM2359424
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 112 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Intravenous (IV) Iron Drugs Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Intravenous (IV) Iron Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Intravenous (IV) Iron Drugs Market Size Growth Rate by Product
      • 1.4.2 Ferric Carboxymaltose
      • 1.4.3 Iron Sucrose
      • 1.4.4 Iron Dextran
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Intravenous (IV) Iron Drugs Market Size Growth Rate by End User
      • 1.5.2 Nephrology
      • 1.5.3 Gynecology & Obstetrics
      • 1.5.4 Gastroenterology
      • 1.5.5 Oncology
      • 1.5.6 Cardiology
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Intravenous (IV) Iron Drugs Market Size
      • 2.1.1 Global Intravenous (IV) Iron Drugs Revenue 2014-2025
      • 2.1.2 Global Intravenous (IV) Iron Drugs Sales 2014-2025
    • 2.2 Intravenous (IV) Iron Drugs Growth Rate by Regions
      • 2.2.1 Global Intravenous (IV) Iron Drugs Sales by Regions
      • 2.2.2 Global Intravenous (IV) Iron Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Intravenous (IV) Iron Drugs Sales by Manufacturers
      • 3.1.1 Intravenous (IV) Iron Drugs Sales by Manufacturers
      • 3.1.2 Intravenous (IV) Iron Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Intravenous (IV) Iron Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Intravenous (IV) Iron Drugs Revenue by Manufacturers
      • 3.2.1 Intravenous (IV) Iron Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Intravenous (IV) Iron Drugs Price by Manufacturers
    • 3.4 Intravenous (IV) Iron Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Intravenous (IV) Iron Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Intravenous (IV) Iron Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Intravenous (IV) Iron Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Intravenous (IV) Iron Drugs Sales by Product
    • 4.2 Global Intravenous (IV) Iron Drugs Revenue by Product
    • 4.3 Intravenous (IV) Iron Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Intravenous (IV) Iron Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Intravenous (IV) Iron Drugs by Countries
      • 6.1.1 North America Intravenous (IV) Iron Drugs Sales by Countries
      • 6.1.2 North America Intravenous (IV) Iron Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Intravenous (IV) Iron Drugs by Product
    • 6.3 North America Intravenous (IV) Iron Drugs by End User

    7 Europe

    • 7.1 Europe Intravenous (IV) Iron Drugs by Countries
      • 7.1.1 Europe Intravenous (IV) Iron Drugs Sales by Countries
      • 7.1.2 Europe Intravenous (IV) Iron Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Intravenous (IV) Iron Drugs by Product
    • 7.3 Europe Intravenous (IV) Iron Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Intravenous (IV) Iron Drugs by Countries
      • 8.1.1 Asia Pacific Intravenous (IV) Iron Drugs Sales by Countries
      • 8.1.2 Asia Pacific Intravenous (IV) Iron Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Intravenous (IV) Iron Drugs by Product
    • 8.3 Asia Pacific Intravenous (IV) Iron Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Intravenous (IV) Iron Drugs by Countries
      • 9.1.1 Central & South America Intravenous (IV) Iron Drugs Sales by Countries
      • 9.1.2 Central & South America Intravenous (IV) Iron Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Intravenous (IV) Iron Drugs by Product
    • 9.3 Central & South America Intravenous (IV) Iron Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Intravenous (IV) Iron Drugs by Countries
      • 10.1.1 Middle East and Africa Intravenous (IV) Iron Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Intravenous (IV) Iron Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Intravenous (IV) Iron Drugs by Product
    • 10.3 Middle East and Africa Intravenous (IV) Iron Drugs by End User

    11 Company Profiles

    • 11.1 Sanofi
      • 11.1.1 Sanofi Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Sanofi Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Sanofi Intravenous (IV) Iron Drugs Products Offered
      • 11.1.5 Sanofi Recent Development
    • 11.2 Allergan
      • 11.2.1 Allergan Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Allergan Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Allergan Intravenous (IV) Iron Drugs Products Offered
      • 11.2.5 Allergan Recent Development
    • 11.3 AMAG Pharmaceuticals
      • 11.3.1 AMAG Pharmaceuticals Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Products Offered
      • 11.3.5 AMAG Pharmaceuticals Recent Development
    • 11.4 Dalichi Sankyo
      • 11.4.1 Dalichi Sankyo Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Dalichi Sankyo Intravenous (IV) Iron Drugs Products Offered
      • 11.4.5 Dalichi Sankyo Recent Development
    • 11.5 Luitpold Pharmaceuticals
      • 11.5.1 Luitpold Pharmaceuticals Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Products Offered
      • 11.5.5 Luitpold Pharmaceuticals Recent Development
    • 11.6 Pharmacosmos
      • 11.6.1 Pharmacosmos Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Pharmacosmos Intravenous (IV) Iron Drugs Products Offered
      • 11.6.5 Pharmacosmos Recent Development
    • 11.7 Takeda Pharmaceutical
      • 11.7.1 Takeda Pharmaceutical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Products Offered
      • 11.7.5 Takeda Pharmaceutical Recent Development

    12 Future Forecast

    • 12.1 Intravenous (IV) Iron Drugs Market Forecast by Regions
      • 12.1.1 Global Intravenous (IV) Iron Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Intravenous (IV) Iron Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Intravenous (IV) Iron Drugs Market Forecast by Product
      • 12.2.1 Global Intravenous (IV) Iron Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Intravenous (IV) Iron Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Intravenous (IV) Iron Drugs Market Forecast by End User
    • 12.4 North America Intravenous (IV) Iron Drugs Forecast
    • 12.5 Europe Intravenous (IV) Iron Drugs Forecast
    • 12.6 Asia Pacific Intravenous (IV) Iron Drugs Forecast
    • 12.7 Central & South America Intravenous (IV) Iron Drugs Forecast
    • 12.8 Middle East and Africa Intravenous (IV) Iron Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Intravenous (IV) Iron Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Iron infusion is a procedure in which iron is delivered to your body intravenously, meaning into a vein through a needle. This method of delivering medication or supplementation is also known as an intravenous (IV) infusion. Iron infusions are usually prescribed by doctors to treat iron deficiency anemia.
      Iron is one of the most important mineral present inside the human body. It carries oxygen throughout the body via the blood, which is further utilized by cells and tissue to get energy for all vital biological processes. Moreover, deficiency of iron leads to severe health problems, such as anemia and also affects mental or other memory functions in youths. To overcome this problem, oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body. For these cases, IV iron therapy is used to as part of which iron is directly injected inside the body with a needle through a vein.
      The global Intravenous (IV) Iron Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous (IV) Iron Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Intravenous (IV) Iron Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous (IV) Iron Drugs in these regions.
      This research report categorizes the global Intravenous (IV) Iron Drugs market by top players/brands, region, type and end user. This report also studies the global Intravenous (IV) Iron Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Sanofi
      Allergan
      AMAG Pharmaceuticals
      Dalichi Sankyo
      Luitpold Pharmaceuticals
      Pharmacosmos
      Takeda Pharmaceutical

      Market size by Product
      Ferric Carboxymaltose
      Iron Sucrose
      Iron Dextran
      Others
      Market size by End User
      Nephrology
      Gynecology & Obstetrics
      Gastroenterology
      Oncology
      Cardiology
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Intravenous (IV) Iron Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Intravenous (IV) Iron Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Intravenous (IV) Iron Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Intravenous (IV) Iron Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Intravenous (IV) Iron Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous (IV) Iron Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Intravenous (IV) Iron Drugs . Industry analysis & Market Report on Intravenous (IV) Iron Drugs is a syndicated market report, published as Global Intravenous (IV) Iron Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Intravenous (IV) Iron Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,121.24
      4,681.87
      6,242.49
      3,534.78
      5,302.17
      7,069.56
      420,747.60
      631,121.40
      841,495.20
      277,240.86
      415,861.29
      554,481.72
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report